{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:16:09Z","timestamp":1770228969166,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,18]]},"DOI":"10.7759\/cureus.48991","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:29:56Z","timestamp":1700303396000},"source":"Crossref","is-referenced-by-count":4,"title":["Pierre-Marie Bamberger Syndrome Leading to the Diagnosis and Surgical Treatment of a Localized Lung Cancer"],"prefix":"10.7759","author":[{"given":"Evangelos","family":"Koliakos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri","family":"Chappalley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Kalogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Sgardello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/j.rdc.2013.02.008","article-title":"Hypertrophic osteoarthropathy: what a rheumatologist should know about this uncommon condition","volume":"39","author":"Pineda C","year":"2013","unstructured":"Pineda C, Mart\u00ednez-Lav\u00edn M. Hypertrophic osteoarthropathy: what a rheumatologist should know about this uncommon condition. Rheum Dis Clin North Am. 2013, 39:383-400.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref2","article-title":"Secondary Hypertrophic Osteoarthropathy","author":"Chakraborty RK","year":"2022","unstructured":"Chakraborty RK, Sharma S. Secondary Hypertrophic Osteoarthropathy. StatPearls [Internet], Treasure Island (FL); 2022."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101507","article-title":"Hypertrophic osteoarthropathy","volume":"34","author":"Mart\u00ednez-Lav\u00edn M","year":"2020","unstructured":"Mart\u00ednez-Lav\u00edn M. Hypertrophic osteoarthropathy. Best Pract Res Clin Rheumatol. 2020, 34:101507. 10.1016\/j.berh.2020.101507","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.07.001","article-title":"Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature","volume":"38","author":"Yao Q","year":"2009","unstructured":"Yao Q, Altman RD, Brahn E. Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum. 2009, 38:458-66. 10.1016\/j.semarthrit.2008.07.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181dc1f3c","article-title":"Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer","volume":"5","author":"Ito T","year":"2010","unstructured":"Ito T, Goto K, Yoh K, et al.. Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer. J Thorac Oncol. 2010, 5:976-80. 10.1097\/JTO.0b013e3181dc1f3c","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017160052","article-title":"Hypertrophic osteoarthropathy: clinical and imaging features","volume":"37","author":"Yap FY","year":"2017","unstructured":"Yap FY, Skalski MR, Patel DB, et al.. Hypertrophic osteoarthropathy: clinical and imaging features. Radiographics. 2017, 37:10.1148\/rg.2017160052","journal-title":"Radiographics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2016.1152672","article-title":"Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance","volume":"71","author":"Callemeyn J","year":"2016","unstructured":"Callemeyn J, Van Haecke P, Peetermans WE, Blockmans D. Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance. Acta Clin Belg. 2016, 71:123-30. 10.1080\/17843286.2016.1152672","journal-title":"Acta Clin Belg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2010.01769.x","article-title":"Incidence of hypertrophic pulmonary osteoarthropathy associated with primary lung cancer","volume":"15","author":"Izumi M","year":"2010","unstructured":"Izumi M, Takayama K, Yabuuchi H, Abe K, Nakanishi Y. Incidence of hypertrophic pulmonary osteoarthropathy associated with primary lung cancer. Respirology. 2010, 15:809-12. 10.1111\/j.1440-1843.2010.01769.x","journal-title":"Respirology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02351.x","article-title":"Pierre Marie-Bamberger syndrome (secondary hypertrophic osteoarthropathy)","volume":"44","author":"Cannav\u00f2 SP","year":"2005","unstructured":"Cannav\u00f2 SP, Guarneri C, Borgia F, Vaccaro M. Pierre Marie-Bamberger syndrome (secondary hypertrophic osteoarthropathy). Int J Dermatol. 2005, 44:41-2. 10.1111\/j.1365-4632.2004.02351.x","journal-title":"Int J Dermatol"},{"key":"ref10","article-title":"Clinical case of the month. Pierre Marie Bamberger syndrome [Article in French]","volume":"61","author":"Rouers A","year":"2006","unstructured":"Rouers A, Radermecker MA, Duysinx B, Kaschten B, Limet R. Clinical case of the month. Pierre Marie Bamberger syndrome [Article in French]. Rev Med Liege. 2006, 61:142-4.","journal-title":"Rev Med Liege"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015900","article-title":"Nociceptive pain unmasking a serious pathology - paraneoplastic hypertrophic osteoarthropathy: a case report","volume":"98","author":"Ribigan AC","year":"2019","unstructured":"Ribigan AC, Bajenaru OL, Antochi FA, Bajenaru OA. Nociceptive pain unmasking a serious pathology - paraneoplastic hypertrophic osteoarthropathy: a case report. Medicine (Baltimore). 2019, 98:e15900. 10.1097\/MD.0000000000015900","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2017.27.118.9084","article-title":"Secondary hypertrophic osteoarthropathy (HOA) or Pierre-Marie Bamberger syndrome revealing bronchial adenocarcinoma [Article in French]","volume":"27","author":"El M'rabet FZ","year":"2017","unstructured":"El M'rabet FZ, Ouahbi H. Secondary hypertrophic osteoarthropathy (HOA) or Pierre-Marie Bamberger syndrome revealing bronchial adenocarcinoma [Article in French]. Pan Afr Med J. 2017, 27:118. 10.11604\/pamj.2017.27.118.9084","journal-title":"Pan Afr Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1291476","article-title":"Hypertrophic pulmonary osteoarthropathy as a cue for NSCLC: four cases in the light of the current literature [Article in German]","volume":"66","author":"Lommatzsch M","year":"2012","unstructured":"Lommatzsch M, Julius P, L\u00fcck W, Bier A, Virchow JC. Hypertrophic pulmonary osteoarthropathy as a cue for NSCLC: four cases in the light of the current literature [Article in German]. Pneumologie. 2012, 66:67-73. 10.1055\/s-0031-1291476","journal-title":"Pneumologie"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/path.1565","article-title":"Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing","volume":"203","author":"Atkinson S","year":"2004","unstructured":"Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol. 2004, 203:721-8. 10.1002\/path.1565","journal-title":"J Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181fc76a9","article-title":"Elevation of prostaglandin E2 in lung cancer patients with digital clubbing","volume":"7","author":"Kozak KR","year":"2012","unstructured":"Kozak KR, Milne GL, Bentzen SM, Yock TI. Elevation of prostaglandin E2 in lung cancer patients with digital clubbing. J Thorac Oncol. 2012, 7:1877-8. 10.1097\/JTO.0b013e3181fc76a9","journal-title":"J Thorac Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(87)91132-9","article-title":"Megakaryocytes and platelet clumps as the cause of finger clubbing","volume":"2","author":"Dickinson CJ","year":"1987","unstructured":"Dickinson CJ, Martin JF. Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet. 1987, 2:1434-5. 10.1016\/s0140-6736(87)91132-9","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2015.09.023","article-title":"Cyclooxygenase-2 expression in non-small cell lung cancer correlates with hypertrophic osteoarthropathy","volume":"101","author":"Rotas I","year":"2016","unstructured":"Rotas I, Cito G, Letovanec I, Christodoulou M, Perentes JY. Cyclooxygenase-2 expression in non-small cell lung cancer correlates with hypertrophic osteoarthropathy. Ann Thorac Surg. 2016, 101:e51-3. 10.1016\/j.athoracsur.2015.09.023","journal-title":"Ann Thorac Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637504","article-title":"Cyclooxygenase-2 inhibitor: a potential combination strategy with immunotherapy in cancer","volume":"11","author":"Pu D","year":"2021","unstructured":"Pu D, Yin L, Huang L, et al.. Cyclooxygenase-2 inhibitor: a potential combination strategy with immunotherapy in cancer. Front Oncol. 2021, 11:637504. 10.3389\/fonc.2021.637504","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3743","article-title":"Phase III randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance)","volume":"35","author":"Edelman MJ","year":"2017","unstructured":"Edelman MJ, Wang X, Hodgson L, et al.. Phase III randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance). J Clin Oncol. 2017, 35:2184-92. 10.1200\/JCO.2016.71.3743","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000082","article-title":"A randomized, placebo-controlled, multicenter, biomarker-selected, phase 2 study of apricoxib in combination with erlotinib in patients with advanced non-small-cell lung cancer","volume":"9","author":"Gitlitz BJ","year":"2014","unstructured":"Gitlitz BJ, Bernstein E, Santos ES, et al.. A randomized, placebo-controlled, multicenter, biomarker-selected, phase 2 study of apricoxib in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Thorac Oncol. 2014, 9:577-82. 10.1097\/JTO.0000000000000082","journal-title":"J Thorac Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/163963-pierre-marie-bamberger-syndrome-leading-to-the-diagnosis-and-surgical-treatment-of-a-localized-lung-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:52Z","timestamp":1707509512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/163963-pierre-marie-bamberger-syndrome-leading-to-the-diagnosis-and-surgical-treatment-of-a-localized-lung-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.48991","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,18]]}}}